Home
About +
Our Story
Meet the Team
FAQs
Our Science +
Inhaled IFN-β
Clinical Trials
Publications
Investors +
Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
Investor Calendar
News +
Press Releases
Resources
Factsheets
TR-1/Options Press Releases
Careers
Contact
Home
About
Our Science
Investors
News
Careers
Contact
Back
Our Story
Meet the Team
FAQs
Back
Inhaled IFN-β
Clinical Trials
Publications
Back
Share Price Information
Reports & Presentations
Investor News
Shareholder Information
AIM Rule 26
Corporate Governance
Investor Calendar
Back
Press Releases
Resources
Factsheets
TR-1/Options Press Releases
Investors
Investor News
Subscribe to news
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
Martin Murphy appointed as Non-Executive Director
16th January 2025
Result of General Meeting and Total Voting Rights
16th January 2025
£18 million raised to fund Phase 2 INVENT clinical trial of SNG001 in ventilated patients with severe viral lung infections
15th January 2025